The elevated expression of NPM1 and FBL in aggressive PCa and their role in PCa progression indicates a potential to develop them as markers of aggressiveness and therapeutic targets for the early detection and treatment of aggressive PCa. This evidence concerns the gene NPM1 and posterior cortical atrophy.